Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Arthritis & Rheumatism

• Publication date

  2007-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.22869PMID 17907188
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T-Cell-Activation Inhibitors in Rheumatoid Arthritis

  2012cited by this paper
• Antibody treatments of inflammatory arthritis.

  2005cited by this paper
• MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis.

  2005cited by this paper
• Tumour necrosis factor activates the mitogen-activated protein kinases p38α and ERK in the synovial membrane in vivo

  2005cited by this paper
• Progress towards therapeutic small molecule MEK inhibitors for use in cancer therapy.

  2005cited by this paper
• Mitogen activated protein kinases as targets for development of novel anti-inflammatory drugs

  2004cited by this paper
• Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis.

  2004cited by this paper
• Signal transduction in rheumatoid arthritis

  2004cited by this paper
• The specificities of protein kinase inhibitors: an update.

  2003cited by this paper
• Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK.

  2003cited by this paper
• The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets.

  2003cited by this paper
• Evolving concepts of rheumatoid arthritis

  2003cited by this paper
• New concepts in the treatment of rheumatoid arthritis.

  2003cited by this paper
• Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis

  2003cited by this paper
• Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis.

  2002cited by this paper
• Mammalian MAP kinase signalling cascades

  2001cited by this paper
• c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

  2001cited by this paper
• The potential of signal transduction inhibitors for the treatment of arthritis: Is it all just JNK?

  2001cited by this paper
• Rheumatoid arthritis.

  2001cited by this paper
• Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia

  2001cited by this paper
• p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.

  2001cited by this paper
• The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1.

  2000cited by this paper
• TNF-a Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway

  2000cited by this paper
• Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo.

  2000cited by this paper
• TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway.

  2000cited by this paper
• Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1.

  2000cited by this paper
• Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.

  2000cited by this paper
• Role of p38 Mitogen-Activated Protein Kinase in a Murine Model of Pulmonary Inflammation1

  2000cited by this paper
• The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL‐1β‐dependent PGE2 release via mechanistically distinct processes

  2000cited by this paper
• Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice.

  1999cited by this paper
• Jun N-terminal kinase in rheumatoid arthritis.

  1999cited by this paper
• Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated proten kinase (MAPKAPK).

  1999cited by this paper
• Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

  1999cited by this paper
• Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/44 mitogen‐activated protein kinase signal transduction pathway

  1999cited by this paper
• Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes.

  1999cited by this paper
• MAP kinase pathways.

  1999cited by this paper
• Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells.

  1999cited by this paper
• Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production by Human Monocytes Involves the Raf-1/MEK1-MEK2/ERK1-ERK2 Pathway

  1999cited by this paper
• Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma.

  1999cited by this paper
• Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in IL-10-mediated selective repression of TNF-alpha-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells.

  1999cited by this paper
• Mitogen‐activated protein kinase and nuclear factor κB together regulate interleukin‐17–induced nitric oxide production in human osteoarthritic chondrocytes: Possible role of transactivating factor mitogen–activated protein kinase–activated protein kinase (MAPKAPK)

  1999cited by this paper
• Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes.

  1998cited by this paper
• Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase*

  1998cited by this paper
• Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy.

  1998cited by this paper
• Ro 09-2210 exhibits potent anti-proliferative effects on activated T cells by selectively blocking MKK activity.

  1998cited by this paper
• Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK

  1997cited by this paper
• Mitogen-activated protein kinase pathways.

  1997cited by this paper
• Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function.

  1996cited by this paper
• Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes.

  1996cited by this paper
• A synthetic inhibitor of the mitogen-activated protein kinase cascade.

  1995cited by this paper
• Collagen-induced arthritis in the mouse.

  1988cited by this paper
• [33] Collagen-induced arthritis in the mouse

  1988cited by this paper
• Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates

  1981cited by this paper

• Potential Crosstalk Between the Renin-Angiotensin System and Neuropilin-1 Pathways in Experimental Rheumatoid Arthritis.

  2026cites this paper
• Molecular Mechanisms of Wound Healing: The Role of Medicinal Plants

  2025cites this paper
• Regulation of inflammatory pathways by cannabigerol in the collagen induced arthritis model in rats

  2025cites this paper
• Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review

  2024cites this paper
• Anti-Inflammatory Effects of a Novel Nuclear Factor–κB Inhibitory Derivative Derived from Pyrazolo[3,4-d]Pyrimidine in Three Inflammation Models

  2024cites this paper
• SIRT6 Reduces Rheumatoid Arthritis Injury by Inhibiting MyD88-ERK Signaling Pathway.

  2024cites this paper
• A novel inhibitor of class IIa histone deacetylases attenuates collagen‐induced arthritis

  2024cites this paper
• Increased mRNA expression of ADAMTS1 and ADAMTS4 in peripheral blood mononuclear cells of psoriasis patients developed psoriatic arthritis

  2024cites this paper
• Inflammation produced by senescent osteocytes mediates age-related bone loss

  2023cites this paper
• A comprehensive review on pharmacological, toxicity, and pharmacokinetic properties of phillygenin: Current landscape and future perspectives.

  2023cites this paper
• PD184352 exerts anti-inflammatory and antioxidant effects by promoting activation of the Nrf2/HO-1 axis.

  2023cites this paper
• 4-Iodo-6-phenylpyrimidine (4-IPP) suppresses fibroblast-like synoviocyte- mediated inflammation and joint destruction associated with rheumatoid arthritis.

  2023cites this paper
• Treating ‘Septic’ With Enhanced Antibiotics and ‘Arthritis’ by Mitigation of Excessive Inflammation

  2022cites this paper
• New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases

  2022cites this paper
• Variations in the Antioxidant, Anticancer, and Anti-Inflammatory Properties of Different Rosa rugosa Organ Extracts

  2022cites this paper
• Orientin inhibits the progression of fibroblast-like synovial cells in rheumatoid arthritis by regulating MAPK-signaling pathway.

  2022cites this paper
• Antcin K inhibits VCAM-1-dependent monocyte adhesion in human rheumatoid arthritis synovial fibroblasts

  2022cites this paper
• BT2 Suppresses Human Monocytic-Endothelial Cell Adhesion, Bone Erosion and Inflammation

  2021cites this paper
• Biological halogen bonds in protein-ligand complexes: a combined QTAIM and NCIPlot study in four representative cases.

  2021cites this paper
• Molecular pharmacology of inflammation: Medicinal plants as antiinflammatory agents

  2021cites this paper
• A review of pharmacological and pharmacokinetic properties of Forsythiaside A.

  2021cites this paper
• Activation of the extracellular-signal-regulated kinase (ERK)/c-Jun N-terminal kinase (JNK) signal pathway and osteogenic factors in subchondral bone of patients with knee osteoarthritis

  2021cites this paper
• Integrated network analysis of symptom clusters across disease conditions

  2020cites this paper
• Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients

  2020cites this paper
• Fortified phosphorus-lowering treatment through administration of lanthanum protects against vascular calcification via regulation of FGF23 in chronic kidney disease

  2020cites this paper
• Mebendazole is unique among tubulin-active drugs in activating the MEK–ERK pathway

  2020cites this paper
• Molecular pharmacology of inflammation: Medicinal plants as anti‐inflammatory agents

  2019cites this paper
• Extracellular Signal-Regulated Kinase: A Regulator of Cell Growth, Inflammation, Chondrocyte and Bone Cell Receptor-Mediated Gene Expression

  2019cites this paper
• FM0807 decelerates experimental arthritis progression by inhibiting inflammatory responses and joint destruction via modulating NF-κB and MAPK pathways

  2019cites this paper
• A novel gene and pathway-level subtyping analysis scheme to understand biological mechanisms in complex disease: a case study in rheumatoid arthritis.

  2019cites this paper
• MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity

  2019cites this paper
• Role of Redox-Active Trace Metal (RATM) Oxidants in the Regulation of Toll-Like Receptor 4 (TLR4) Signaling-Mediated Inflammatory Phenotype in Synovial Fibroblasts

  2018influential citation
• Therapeutic Effect of Penta-acetyl Geniposide on Adjuvant-Induced Arthritis in Rats: Involvement of Inducing Synovial Apoptosis and Inhibiting NF-κB Signal Pathway

  2018cites this paper
• Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor

  2018cites this paper
• Docking study and antiosteoporosis effects of a dibenzylbutane lignan isolated from Litsea cubeba targeting Cathepsin K and MEK1

  2018cites this paper
• Inflammatory but not mitogenic contexts prime synovial fibroblasts for compensatory signaling responses to p38 inhibition

  2018cites this paper
• Encorafenib and Binimetinib: First Global Approvals

  2018cites this paper
• Sonic Hedgehog Signaling Pathway Mediates Proliferation and Migration of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via MAPK/ERK Signaling Pathway

  2018cites this paper
• Natural Products as Source of Anti‐Inflammatory Drugs

  2017cites this paper
• Triptolide protects bone against destruction by targeting RANKL-mediated ERK/AKT signalling pathway in the collagen-induced rheumatoid arthritis

  2017cites this paper
• Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis

  2017cites this paper
• Human umbilical cord mesenchymal stem cells alleviate acute myocarditis by modulating endoplasmic reticulum stress and extracellular signal regulated 1/2-mediated apoptosis

  2017cites this paper
• Exploiting the helminth-derived immunomodulator, ES-62 and its small molecule analogues to dissect the mechanisms underpinning the development of the pathogenic phenotype of synovial fibroblasts in autoimmune arthritis.

  2017cites this paper
• &bgr;2‐receptor agonists salbutamol and terbutaline attenuated cytokine production by suppressing ERK pathway through cAMP in macrophages

  2017cites this paper
• Preclinical Assessment of Inflammatory Pain

  2016cites this paper
• Investigation of the roles of acid sensing proteins in rheumatoid arthritis

  2016cites this paper
• Apoptotic Effect of Geniposide on Fibroblast-Like Synoviocytes in Rats with Adjuvant-Induced Arthritis via Inhibiting ERK Signal Pathway In Vitro

  2015cites this paper
• Small molecular inhibitors for the treatment of rheumatoid arthritis: progress so far.

  2015cites this paper
• Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis.

  2015cites this paper
• Mangiferin suppresses CIA by suppressing the expression of TNF-α, IL-6, IL-1β, and RANKL through inhibiting the activation of NF-κB and ERK1/2.

  2015cites this paper
• Mitogen-activated Protein Kinase Phosphatases in Inflammation and as Anti-inflammatory Drug Targets

  2014cites this paper
• MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition.

  2014cites this paper
• Caveolin-1 deficiency induces a MEK-ERK1/2-Snail-1-dependent epithelial–mesenchymal transition and fibrosis during peritoneal dialysis

  2014cites this paper
• Therapeutic targets for rheumatoid arthritis: Progress and promises

  2014cites this paper
• Humulus scandens exhibits immunosuppressive effects in vitro and in vivo by suppressing CD4(+) T cell activation.

  2014cites this paper
• Signaling pathway interactions and their inhibition in healthy and RA B cells

  2014cites this paper
• Ras-ERK signalling in endochondral ossification: insights from neurofibromin

  2014cites this paper
• Protein Kinase Inhibitors in Rheumatology

  2014cites this paper
• Activated Protein C Inhibits Proliferation and Tumor Necrosis Factor α – Stimulated Activation of p 38 , c-Jun NH 2-Terminal Kinase ( JNK ) and Akt in Rheumatoid Synovial Fibroblasts

  2013cites this paper
• Mitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis

  2013cites this paper
• Activated Protein C Inhibits Proliferation and Tumor Necrosis Factor α-Stimulated Activation of p38, c-Jun NH2-Terminal Kinase (JNK) and Akt in Rheumatoid Synovial Fibroblasts

  2013cites this paper
• Inhibitory effect of the antimalarial agent artesunate on collagen-induced arthritis in rats through nuclear factor kappa B and mitogen-activated protein kinase signaling pathway.

  2013cites this paper
• Effect of locally administered Syk siRNA on allergen-induced arthritis and asthma.

  2013cites this paper
• Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells

  2013cites this paper
• Mitogen-activated protein kinases in innate immunity

  2013cites this paper
• Estrogen inhibits apoptosis and promotes CC motif chemokine ligand 13 expression on synovial fibroblasts in rheumatoid arthritis

  2012cites this paper
• Combination of MEK-ERK inhibitor and hyaluronic acid has a synergistic effect on anti-hypertrophic and pro-chondrogenic activities in osteoarthritis treatment

  2012cites this paper
• Immunopathological Roles of Cytokines, Chemokines, Signaling Molecules, and Pattern-Recognition Receptors in Systemic Lupus Erythematosus

  2012cites this paper
• Characterization of the Phosphoproteome in SLE Patients

  2012cites this paper
• Cellular Targeting in Autoimmunity

  2012cites this paper
• Small-molecule protein and lipid kinase inhibitors in inflammation and specific models for their evaluation.

  2012cites this paper
• Design and synthesis of orally available MEK inhibitors with potent in vivo antitumor efficacy.

  2012cites this paper
• BIOLOGICS IN RHEUMATOLOGY 2012

  2012cites this paper
• Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide

  2012cites this paper
• [New kinase inhibitors].

  2012cites this paper
• Herbal medicinal products target defined biochemical and molecular mediators of inflammatory autoimmune arthritis.

  2011cites this paper
• Selective ERK Activation Differentiates Mouse and Human Tolerogenic Dendritic Cells, Expands Antigen-Specific Regulatory T Cells, and Suppresses Experimental Inflammatory Arthritis

  2011cites this paper
• Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes.

  2011cites this paper
• Blocking MAPK signaling downregulates CCL21 in lymphatic endothelial cells and impairs contact hypersensitivity responses.

  2011cites this paper
• Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer.

  2011cites this paper
• Fully activated MEK1 exhibits compromised affinity for binding of allosteric inhibitors U0126 and PD0325901.

  2011cites this paper
• Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets

  2011cites this paper
• Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study aimed at identifi cation of diagnostic and prognostic biomarkers as well as therapeutic targets

  2011cites this paper
• Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study aimed at identifi cation of diagnostic and prognostic biomarkers as well as therapeutic targets

  2011cites this paper
• Blocking ERK-1/2 reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein A.

  2010cites this paper
• [Mechanisms involved in the regulation of immune response in animal model of rheumatoid arthritis in mice (CIA)].

  2010cites this paper
• Interleukin‐1 β increases gap junctional communication among synovial fibroblasts via the extracellular‐signal‐regulated kinase pathway

  2010influential citation
• Elevated GM-CSF and IL-1beta levels compromise the ability of p38 MAPK inhibitors to modulate TNFalpha levels in the human monocytic/macrophage U937 cell line.

  2010cites this paper
• A multitude of kinases--which are the best targets in treating rheumatoid arthritis?

  2010cites this paper
• Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis

  2010cites this paper
• UvA-DARE ( Digital Academic Repository ) Ras family GTPase signaling contributions to inflammation and joint destruction in rheumatoid arthritis

  2010cites this paper
• The Discovery of Novel Experimental Therapies for Inflammatory Arthritis

  2010cites this paper
• Signal pathways regulating hyaluronan secretion into static and cycled synovial joints of rabbits

  2009cites this paper
• Attenuates Autoimmune Disease and IL-1-Driven IL-17 Production and Inhibition of ERK MAPK Suppresses IL-23-C.

  2009cites this paper
• Garden of therapeutic delights: new targets in rheumatic diseases

  2009cites this paper
• Targeting innate immunity protein kinase signalling in inflammation

  2009cites this paper
• Inhibition of ERK MAPK Suppresses IL-23-

  2009cites this paper
• Vanilloid receptor TRPV1-mediated phosphorylation of ERK in murine adjuvant arthritis.

  2009cites this paper
• Intracellular signal pathways: Potential for therapies

  2009cites this paper
• Activation Profile of Intracellular Mitogen-Activated Protein Kinases in Peripheral Lymphocytes of Patients with Systemic Lupus Erythematosus

  2009cites this paper